文献速递瓣膜病与结构性心脏病肺血管病与心包/心肌炎

重度三尖瓣反流中肺动脉高压的临床特征、诊断与风险分层及其对经导管三尖瓣修复的意义

Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair.
PubMed 文献 · Eur Heart J · 2020-01-01

随访330天显示,有创与超声诊断不一致(iPHT+/ePHT-)的患者联合临床终点风险最高(HR 3.76),超声诊断准确性仅55%。

要点

  • 重度三尖瓣反流患者中,有创与超声对肺动脉高压的诊断常不一致,超声准确性仅55%。
  • iPHT+/ePHT- discordant诊断与TTVR术后联合终点风险显著升高相关(HR 3.76)。
  • TTVR手术成功率在iPHT+与iPHT-患者中相似(84% vs. 84%)。

核心结论

  • 重度三尖瓣反流患者中,有创与超声对肺动脉高压诊断不一致可预测TTVR术后结局,iPHT+/ePHT-患者联合终点风险最高。

主要发现

  • iPHT+患者术前风险更高(P<0.01)、症状更重(P=0.01)、NT-proBNP更高(P<0.01)、右室功能及后负荷校正右室功能更差(P<0.01)。
  • TTVR手术成功率在iPHT+与iPHT-患者中相似(84% vs. 84%,P=0.99)。
  • 超声诊断iPHT的准确性仅55%。
  • 随访330天(IQR 175-402)期间,35%患者达到联合临床终点。

关键数值与推荐

  • 有创肺动脉高压定义为有创收缩期肺动脉压≥50 mmHg。
  • 联合临床终点包括死亡、心力衰竭住院和再干预。
  • 在孤立三尖瓣手术患者(n=131)中,iPHT+/ePHT-不一致诊断及后负荷校正右室功能受损均为联合终点的独立预测因素(P<0.01)。

临床怎么用

  • 对重度三尖瓣反流拟行TTVR的患者,应结合有创肺动脉压评估,不能仅依赖超声诊断肺动脉高压。
  • 有创与超声诊断不一致(iPHT+/ePHT-)提示术后高风险,需加强围术期管理及随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Patients with pulmonary hypertension (PHT) are often excluded from surgical therapies for tricuspid regurgitation (TR). Transcatheter tricuspid valve repair (TTVR) with the MitraClip™ technique is a novel treatment option for these patients. We aimed to assess the role of PHT in severe TR and its implications for TTVR. METHODS AND RESULTS: A total of 243 patients underwent TTVR at two centres. One hundred twenty-one patients were grouped as iPHT+ [invasive systolic pulmonary artery pressures (PAPs) ≥50 mmHg]. Patients were similarly stratified according to echocardiographic PAPs (ePHT). The occurrence of the combined clinical endpoint (death, heart failure hospitalization, and reintervention) was investigated during a follow-up of 330 (interquartile range 175-402) days. iPHT+ patients were at higher preoperative risk (P < 0.01), had more severe symptoms (P = 0.01), higher N-terminal pro-B-type natriuretic peptide levels (P < 0.01), more impaired right ventricular (RV) function (P < 0.01), and afterload corrected RV function (P < 0.01). Procedural TTVR success was similar in iPHT+ and iPHT- patients (84 vs. 84%, P = 0.99). The echocardiographic diagnostic accuracy to detect iPHT was only 55%. During follow-up, 35% of patients reached the combined clinical endpoint. The discordant diagnosis of iPHT+/ePHT- carried the highest risk for the combined clinical endpoint [HR 3.76 (CI 2.25-6.37), P < 0.01], while iPHT+/ePHT+ patients had a similar survival-free time from the combined endpoint compared to iPHT- patients (P = 0.48). In patients with isolated tricuspid procedure (n = 131) a discordant iPHT+/ePHT- diagnosis and an impaired afterload corrected RV function (P < 0.01 for both) were independent predictors for the occurrence of the combined endpoint. CONCLUSION: The discordant echocardiographic and invasive diagnosis of PHT in severe TR predicts outcomes after TTVR.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Lurz P, Orban M, Besler C, et al. Clinical characteristics, diagnosis, and risk stratification of pulmonary hypertension in severe tricuspid regurgitation and implications for transcatheter tricuspid valve repair. Eur Heart J. 2020. PMID: 32176280. doi:10.1093/eurheartj/ehaa138

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。